# Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial) and COAPT CAS

> **NCT01626079** · NA · UNKNOWN · sponsor: **Abbott Medical Devices** · enrollment: 776 (actual)

## Conditions studied

- Mitral Regurgitation
- Mitral Valve Regurgitation
- Treatment of Functional Mitral Regurgitation in Symptomatic Heart Failure Subjects
- Heart Failure

## Interventions

- **DEVICE:** MitraClip System

## Key facts

- **NCT ID:** NCT01626079
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-08
- **Primary completion:** 2019-03
- **Final completion:** 2024-07
- **Target enrollment:** 776 (ACTUAL)
- **Last updated:** 2023-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01626079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01626079, "Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial) and COAPT CAS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01626079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*